The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Hsa-miR-31-3p expression in FFPE tumor samples as a predictor of anti-EGFR response in patients with metastatic colorectal cancer.
Gilles Manceau
No relevant relationships to disclose
Jean-Baptiste Bachet
No relevant relationships to disclose
Benoist Chibaudel
No relevant relationships to disclose
Francois Liebaert
Employment or Leadership Position - IntegraGen
Raphaële Thiébaut
Employment or Leadership Position - IntegraGen
Pieter Demetter
No relevant relationships to disclose
Jean-Luc Van Laethem
No relevant relationships to disclose
Karen Leroy
No relevant relationships to disclose
Olivier Bouche
No relevant relationships to disclose
Frederique Penault-Llorca
No relevant relationships to disclose
Marie Danielle Diebold
No relevant relationships to disclose
Thierry André
Consultant or Advisory Role - Amgen
Honoraria - Merck Serono
Sandrine Imbeaud
No relevant relationships to disclose
Pierre Laurent-Puig
Consultant or Advisory Role - IntegraGen